Clinical Trial Update: Effect of KYG0395 on Primary Dysmenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating KYG0395 for primary dysmenorrhea has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• KYG0395

Snippet

Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd | Conditions: Primary Dysmenorrhea | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26